Previous Article | Next Article 
Journal of Bacteriology, January 2000, p. 400-404, Vol. 182, No. 2
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Activation of the Multiple Drug Resistance Gene
MDR1 in Fluconazole-Resistant, Clinical Candida
albicans Strains Is Caused by Mutations in a
trans-Regulatory Factor
Stephanie
Wirsching,
Sonja
Michel,
Gerwald
Köhler, and
Joachim
Morschhäuser*
Zentrum für Infektionsforschung,
Universität Würzburg, Röntgenring 11, D-97070
Würzburg, Germany
Received 26 July 1999/Accepted 20 October 1999
Resistance of Candida albicans against the widely used
antifungal agent fluconazole is often due to active drug efflux from the cells. In many fluconazole-resistant C. albicans
isolates the reduced intracellular drug accumulation correlates with
constitutive strong expression of the MDR1 gene, encoding a
membrane transport protein of the major facilitator superfamily that is
not detectably expressed in vitro in fluconazole-susceptible isolates.
To elucidate the molecular changes responsible for MDR1
activation, two pairs of matched fluconazole-susceptible and resistant
isolates in which drug resistance coincided with stable
MDR1 activation were analyzed. Sequence analysis of the
MDR1 regulatory region did not reveal any promoter
mutations in the resistant isolates that might account for the altered
expression of the gene. To test for a possible involvement of
trans-regulatory factors, a GFP reporter gene
was placed under the control of the MDR1 promoter from the
fluconazole-susceptible C. albicans strain CAI4, which does
not express the MDR1 gene in vitro. This
MDR1P-GFP fusion was integrated into the genome of the
clinical C. albicans isolates with the help of the dominant selection marker MPAR developed for the
transformation of C. albicans wild-type strains. Integration was targeted to an ectopic locus such that no recombination between the heterologous and resident MDR1 promoters
occurred. The transformants of the two resistant isolates exhibited a
fluorescent phenotype, whereas transformants of the corresponding
susceptible isolates did not express the GFP gene. These
results demonstrate that the MDR1 promoter was activated by
a trans-regulatory factor that was mutated in
fluconazole-resistant isolates, resulting in deregulated, constitutive
MDR1 expression.
*
Corresponding author. Mailing address: Zentrum
für Infektionsforschung, Universität Würzburg,
Röntgenring 11, D-97070 Würzburg, Germany. Phone: 49-931-31 21 52. Fax: 49-931-31 25 78. E-mail:
joachim.morschhaeuser{at}mail.uni-wuerzburg.de.
Journal of Bacteriology, January 2000, p. 400-404, Vol. 182, No. 2
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Znaidi, S., Weber, S., Zin Al-Abdin, O., Bomme, P., Saidane, S., Drouin, S., Lemieux, S., De Deken, X., Robert, F., Raymond, M.
(2008). Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance. Eukaryot Cell
7: 836-847
[Abstract]
[Full Text]
-
Manoharlal, R., Gaur, N. A., Panwar, S. L., Morschhauser, J., Prasad, R.
(2008). Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans. Antimicrob. Agents Chemother.
52: 1481-1492
[Abstract]
[Full Text]
-
Cheng, S., Clancy, C. J., Nguyen, K. T., Clapp, W., Nguyen, M. H.
(2007). A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole. Antimicrob. Agents Chemother.
51: 1855-1858
[Abstract]
[Full Text]
-
Rognon, B., Kozovska, Z., Coste, A. T., Pardini, G., Sanglard, D.
(2006). Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance. Microbiology
152: 3701-3722
[Abstract]
[Full Text]
-
Riggle, P. J., Kumamoto, C. A.
(2006). Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site. Eukaryot Cell
5: 1957-1968
[Abstract]
[Full Text]
-
Hiller, D., Stahl, S., Morschhauser, J.
(2006). Multiple cis-Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate.. Antimicrob. Agents Chemother.
50: 2300-2308
[Abstract]
[Full Text]
-
Bader, T., Schroppel, K., Bentink, S., Agabian, N., Kohler, G., Morschhauser, J.
(2006). Role of Calcineurin in Stress Resistance, Morphogenesis, and Virulence of a Candida albicans Wild-Type Strain. Infect. Immun.
74: 4366-4369
[Abstract]
[Full Text]
-
Hiller, D., Sanglard, D., Morschhauser, J.
(2006). Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans.. Antimicrob. Agents Chemother.
50: 1365-1371
[Abstract]
[Full Text]
-
Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G., Coleman, D. C., Sullivan, D. J.
(2005). Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression. Antimicrob. Agents Chemother.
49: 1312-1318
[Abstract]
[Full Text]
-
Vermitsky, J.-P., Edlind, T. D.
(2004). Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor. Antimicrob. Agents Chemother.
48: 3773-3781
[Abstract]
[Full Text]
-
Karababa, M., Coste, A. T., Rognon, B., Bille, J., Sanglard, D.
(2004). Comparison of Gene Expression Profiles of Candida albicans Azole-Resistant Clinical Isolates and Laboratory Strains Exposed to Drugs Inducing Multidrug Transporters. Antimicrob. Agents Chemother.
48: 3064-3079
[Abstract]
[Full Text]
-
De Deken, X., Raymond, M.
(2004). Constitutive Activation of the PDR16 Promoter in a Candida albicans Azole-Resistant Clinical Isolate Overexpressing CDR1 and CDR2. Antimicrob. Agents Chemother.
48: 2700-2703
[Abstract]
[Full Text]
-
Rogers, P. D., Barker, K. S.
(2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother.
47: 1220-1227
[Abstract]
[Full Text]
-
Cowen, L. E., Nantel, A., Whiteway, M. S., Thomas, D. Y., Tessier, D. C., Kohn, L. M., Anderson, J. B.
(2002). Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA
99: 9284-9289
[Abstract]
[Full Text]
-
Wirsching, S., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhauser, J.
(2001). MDR1-Mediated Drug Resistance in Candida dubliniensis. Antimicrob. Agents Chemother.
45: 3416-3421
[Abstract]
[Full Text]
-
Staib, P., Moran, G. P., Sullivan, D. J., Coleman, D. C., Morschhäuser, J.
(2001). Isogenic Strain Construction and Gene Targeting in Candida dubliniensis. J. Bacteriol.
183: 2859-2865
[Abstract]
[Full Text]
-
Uhl, M. A., Johnson, A. D.
(2001). Development of Streptococcus thermophilus lacZ as a reporter gene for Candida albicans. Microbiology
147: 1189-1195
[Abstract]
[Full Text]